Enjoying life and family
Carolina Palacios de Ramirez is enjoying life again following a procedure at OHSU on Aug. 27 that marked the first clinical use of incisionless surgery for the treatment of Parkinson's disease in the United States. (Courtesy of Carolina Sandoval)
Enjoying life and family
Carolina Palacios de Ramirez is enjoying life again following a procedure at OHSU on Aug. 27 that marked the first clinical use of incisionless surgery for the treatment of Parkinson's disease in the United States. (Courtesy of Carolina Sandoval)
Enjoying life and family
Carolina Palacios de Ramirez is enjoying life again following a procedure at OHSU on Aug. 27 that marked the first clinical use of incisionless surgery for the treatment of Parkinson's disease in the United States. (Courtesy of Carolina Sandoval)
Lee Neilson, M.D. (OHSU)
Gregory D. Scott, M.D., Ph.D. (OHSU)
Lee Neilson, M.D. and Gregory Scott, M.D., Ph.D.
El Dr. Lee Neilson, a la izquierda, y el Dr. Gregory Scott, Ph.D., se encuentran entre los coautores de un nuevo estudio que involucra millones de registros médicos electrónicos y revela que la apnea obstructiva del sueño no tratada aumenta el riesgo de enfermedad de Parkinson. (OHSU/Christine Torres Hicks)
Study implicates enzyme in neurodegenerative conditions
Larry Sherman, Ph.D., professor at OHSU’s Oregon National Primate Research Center, led research identifying the enzyme CEMIP as a key player in myelin breakdown linked to conditions like multiple sclerosis, stroke, and Alzheimer’s disease. (OHSU/Christine Torres Hicks)
Rebecca Spain, M.D., M.S.P.H. (OHSU)
Study: Mixed results in using lipoic acid to treat progressive multiple sclerosis
Rebecca Spain, M.D., M.S.P.H., is lead author on a new randomized controlled clinical trial testing the over-the-counter supplement lipoic acid in treating progressive forms of multiple sclerosis. (OHSU/Christine Torres Hicks)
